Valentina completed her Master of Pharmacy (MPharm) at the University of Rome Tor Vergata, graduating with a first-class on October 2017. Her final year included a research placement funded by Boots Alliance at the University of Nottingham, in which she focused on investigating the role of BCL-2 protein in the regulating the expression of estrogen receptor in triple-negative breast cancer. She also undertook 6 months training in a community pharmacy as part of her undergraduate module.
Valentina joined the CDT in advanced therapeutics and Nanomedicine in September 2017, and was awarded the prestigious Vice-Chancellor's Scholarship for Research Excellence.
Her first training project under the supervision of Dr Pavel Gershkovich, was involved in the pharmacokinetic assessment of apomorphine and it's lopiphilic prodrugs in vitro. On her second training project in AstraZeneca, Valentina worked on the development of an analytical method for physical characterization of a dendrimer-based nanoparticle in complex media.
Valentina is now in the first year of her PhD, developing of an oral formulation to enhance the bioavailability of poorly absorbed compounds breaking lipinski's rules, under the supervision of Dr… read more
Valentina is now in the first year of her PhD, developing of an oral formulation to enhance the bioavailability of poorly absorbed compounds breaking lipinski's rules, under the supervision of Dr Maria Marlow, Dr Pavel Gershkovich and Dr Michael stocks (The University Of Nottingham), Susan Barker (UCL), James Butler (GlaxoSmithKline).